Cancer Vaccine Institute News

On October 30, the FDA granted accelerated approval to Voceryq, the first-ever plasmid DNA-based immunotherapy, developed by Inovio Pharmaceuticals. The treatment delivers two plasmids to help the immune system target cells infected with human papillomavirus (HPV), which are responsible for recurrent respiratory papillomatosis (RRP). The FDA’s approval marks an important milestone for DNA-based therapeutics and could help advance research in this field. Cancer Vaccine Institu

Dr. Nora Disis, Director of the Cancer Vaccine Institute (CVI), spoke with FOX 13’s Claire Anderson to share encouraging clinical trial results and discuss the growing promise of breast cancer vaccines. The CVI is developing breast cancer vaccines that can program the body’s own immune system to recognize and kill breast cancer cells. These immune cells are capable of remaining in the body for years, providing long-term protection from cancer coming back. Dr. Disis explains,

Last week, KING 5 News featured ongoing research at the Cancer Vaccine Institute (CVI) to develop COLOVAC, a preventive vaccine designed to stop colon cancer before it starts. The segment included interviews with CVI Director Dr. Nora Disis and Becky Bruhn, a Seattle resident whose recent cancerous polyp illustrates the importance of early detection and need for new prevention tools. Colon cancer remains one of the leading causes of cancer death in the United States, and rate

Photos from the October 23rd event include: Dr. Nora Disis (CVI Director), Dr. Robert Jones (University of Washington President), Dr. Lynn Hassan Jones, Dr. Tim Dellit (UW Medicine CEO), Jean Enersen (Former KING5 News Anchor), Pramila Jayapal (US House of Representatives), Susan Bevan (CVI Development Council Member) October was a powerful month at the University of Washington, as Husky Athletics partnered with the Huskies for a Cure campaign to raise awareness and funds fo

Last week at the Cancer Vaccine Institute, we witnessed a moment of joy, pride, and profound recognition as Dr. Nora Disis was honored as a Delta Community Captain . In a surprise event filled with CVI lab members, Seahawks representatives, Delta Air Lines team members, and Dr. Disis’ family, the room erupted in celebration of a scientist whose work is transforming the future of breast cancer care. The Delta Community Captain program, powered by Delta Air Lines in partnership